stars 1 stars 2 stars 3

Micrographia Bio is an applied AI-first life sciences company pioneering a new era of drug discovery through nanoscale spatial proteomics. We dive deep into visualising individual proteins and their interactions in their native spatial context, and have developed an end-to-end platform for the quantification of changes in protein behaviour and mechanism of action at scale. By revealing where and how proteins interact, we unlock unprecedented insights into complex biology to increase the probability of success at the earliest stages of discovery. We are advancing internal pipeline therapeutic candidates focused on fundamental cellular pathways, and are partnering with drug discovery programmes to characterise mechanism of action with precision. Learn more at www.Micrographiabio.com, or connect on LinkedIn.

Micrographia Bio Questions

Christopher Thompson is the Co-founder and CTO of Micrographia Bio.

9 people are employed at Micrographia Bio.

Micrographia Bio is based in London, England.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users